Our round-up of biotech financings is led this week by Braveheart Bio, a San Francisco biotech that has launched with $185 million, a lead drug for hypertrophic cardiomyopathy (HCM), and Biogen CEO ...
What does this Advisor Specialize in? Find a financial advisor who specializes in the area of expertise you require. It's important to find an advisor who can help you approach your personal and ...
Products Market Alerts MyCollection Price Database Become a Partner Gallery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results